Show simple item record

dc.contributor.authorButler, J
dc.contributor.authorHandy, RD
dc.contributor.authorUpton, M
dc.contributor.authorBesinis, A
dc.date.accessioned2023-04-11T08:32:07Z
dc.date.issued2023-04-07
dc.date.updated2023-04-10T08:38:09Z
dc.description.abstractThis review discusses topics relevant to the development of antimicrobial nanocoatings and nanoscale surface modifications for medical and dental applications. Nanomaterials have unique properties compared to their micro- and macro-scale counterparts and can be used to reduce or inhibit bacterial growth, surface colonization and biofilm development. Generally, nanocoatings exert their antimicrobial effects through biochemical reactions, production of reactive oxygen species or ionic release, while modified nanotopographies create a physically hostile surface for bacteria, killing cells via biomechanical damage. Nanocoatings may consist of metal nanoparticles including silver, copper, gold, zinc, titanium, and aluminum, while nonmetallic compounds used in nanocoatings may be carbon-based in the form of graphene or carbon nanotubes, or composed of silica or chitosan. Surface nanotopography can be modified by the inclusion of nanoprotrusions or black silicon. Two or more nanomaterials can be combined to form nanocomposites with distinct chemical or physical characteristics, allowing combination of different properties such as antimicrobial activity, biocompatibility, strength, and durability. Despite their wide range of applications in medical engineering, questions have been raised regarding potential toxicity and hazards. Current legal frameworks do not effectively regulate antimicrobial nanocoatings in matters of safety, with open questions remaining about risk analysis and occupational exposure limits not considering coating-based approaches. Bacterial resistance to nanomaterials is also a concern, especially where it may affect wider antimicrobial resistance. Nanocoatings have excellent potential for future use, but safe development of antimicrobials requires careful consideration of the “One Health” agenda, appropriate legislation, and risk assessment.en_GB
dc.identifier.citationPublished online 7 April 2023en_GB
dc.identifier.doihttps://doi.org/10.1021/acsnano.2c12488
dc.identifier.urihttp://hdl.handle.net/10871/132884
dc.identifierORCID: 0000-0003-1998-1219 (Butler, James)
dc.language.isoenen_GB
dc.publisherAmerican Chemical Society (ACS)en_GB
dc.rights© 2023 The Authors. Published by American Chemical Society. Open access under a CC BY 4 licenceen_GB
dc.subjectantimicrobialen_GB
dc.subjectresistanceen_GB
dc.subjectantibacterialen_GB
dc.subjectantibiofilmen_GB
dc.subjectantibioticsen_GB
dc.subjectnanoparticleen_GB
dc.subjectnanomaterialen_GB
dc.subjectnanocoatingen_GB
dc.subjectsurfaceen_GB
dc.subjectsafetyen_GB
dc.titleReview of Antimicrobial Nanocoatings in Medicine and Dentistry: Mechanisms of Action, Biocompatibility Performance, Safety, and Benefits Compared to Antibioticsen_GB
dc.typeArticleen_GB
dc.date.available2023-04-11T08:32:07Z
dc.identifier.issn1936-0851
dc.descriptionThis is the final version. Available on open access from the American Chemical Society via the DOI in this recorden_GB
dc.identifier.eissn1936-086X
dc.identifier.journalACS Nanoen_GB
dc.relation.ispartofACS Nano
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-03-17
dcterms.dateSubmitted2022-12-16
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-03-17
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-04-10T08:38:21Z
refterms.versionFCDVoR
refterms.dateFOA2023-04-11T08:32:08Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-04-07


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Published by American Chemical Society. Open access under a CC BY 4 licence
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Published by American Chemical Society. Open access under a CC BY 4 licence